Bank of Montreal
TEVA icon

Bank of Montreal’s Teva Pharmaceuticals TEVA Stock Holding History

Bank of Montreal’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-200,000
Closed -$1.62M – 4829
2020
Q1 		$1.62M Sell
200,000
-782,500
-80% -$8.02M ﹤0.01% 1516
2019
Q4 		$9.63M Buy
982,500
+820,000
+505% +$7.32M 0.01% 1002
2019
Q3 		$1.12M Buy
+162,500
New +$1.25M ﹤0.01% 2011
2018
Q3 		– Sell
-30,000
Closed -$730K – 4883
2018
Q2 		$730K Buy
+30,000
New +$612K ﹤0.01% 2158

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Bank of Montreal's TEVA Position: Q2 2026 in Review

Bank of Montreal increased its Teva Pharmaceuticals (TEVA) stake by 10% in Q2 2026, buying an estimated $3.07M and bringing the position to 971,583 shares worth $32.9M. The position accounts for 0.01% of the portfolio, ranked #733.

Bank of Montreal first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $93.2M in Q1 2015. 419 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Bank of Montreal held 971,583 shares of Teva Pharmaceuticals worth $32.9M as of Q2 2026.
  • Bank of Montreal bought 92,238 Teva Pharmaceuticals shares in Q2 2026, an estimated $3.07M.
  • Teva Pharmaceuticals made up 0.01% of Bank of Montreal's portfolio in Q2 2026, its #733 holding.
  • Bank of Montreal first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's Teva Pharmaceuticals position peaked at $93.2M in Q1 2015.
  • 419 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.